Triazole derivatives as tachykinin receptor antagonists

Details for Australian Patent Application No. 2003230829 (hide)

Owner Eli Lilly and Company

Inventors Hembre, Erik, James; Muehl, Brian, Stephen; Amegadzie, Albert, Kudzovi; Robertson, Michael, Alan; Jungheim, Louis, Nickolaus; Savin, Kenneth, Allen; Remick, David, Michael; Hong, Jian, Eric; Gardiner, Kevin, Matthew

Agent Spruson & Ferguson

Pub. Number AU-B-2003230829

PCT Number PCT/US03/10681

PCT Pub. Number WO2003/091226

Priority 60/376,121 26.04.02 US

Filing date 22 April 2003

Wipo publication date 10 November 2003

Acceptance publication date 4 December 2008

International Classifications

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/437 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/497 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/376,121 26.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-B-2003230829

4 December 2008 Application Accepted

  Published as AU-B-2003230829

11 December 2008 Corrigenda

  Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003230829, under INID(72) correct the co-inventor name to Gardinier, Kevin Matthew Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002354120 The Yokohama Rubber Co., Ltd. 2004201062 The Penn State Research Foundation 2005202046 Bayer Schering Pharma Aktiengesellschaft

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003230830-TREATMENT OF TYPE 1 DIABETES BEFORE AND AFTER EXPRESSION OF PREDISPOSITION MARKERS

2003230828-SYSTEM FOR RATING CONSTRUCTED RESPONSES BASED ON CONCEPTS AND A MODEL ANSWER